help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on May 1, 2008
Endocrinology, doi:10.1210/en.2008-0050
This Article
Right arrow Author Manuscript (PDF)
Right arrow Supplemental Data
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Blumer, J. B.
Right arrow Articles by Lanier, S. M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Blumer, J. B.
Right arrow Articles by Lanier, S. M.

Submitted on January 15, 2008
Accepted on April 23, 2008

ACTIVATOR OF G-PROTEIN SIGNALING 3 NULL MICE: I. UNEXPECTED ALTERATIONS IN METABOLIC AND CARDIOVASCULAR FUNCTION

Joe B. Blumer, Kevin Lord, Thomas L. Saunders, Alejandra Pacchioni, Cory Black, Eric Lazartigues, Kurt J. Varner, Thomas W. Gettys, and Stephen M. Lanier*

Department of Pharmacology and Experimental Therapeutics, LSU Health Sciences Center, New Orleans, LA 70112; Department of Internal Medicine, Transgenic Animal Model Core, University of Michigan, Ann Arbor, MI 48109; Division of Experimental Obesity, Pennington Biomedical Research Center, Baton Rouge, LA 70808; Department of Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston, SC 29425

* To whom correspondence should be addressed. E-mail: laniersm{at}musc.edu.

Activator of G-protein Signaling (AGS) 3 plays functional roles in cell division, synaptic plasticity, addictive behavior and neuronal development. As part of a broad effort to define the extent of functional diversity of AGS3-regulated-events in vivo, we generated AGS3 null mice. Surprisingly, AGS3 null adult mice exhibited unexpected alterations in cardiovascular and metabolic functions without any obvious changes in motor skills, basic behavioral traits and brain morphology. AGS3 null mice exhibited a lean phenotype, reduced fat mass and increased nocturnal energy expenditure. AGS3 null mice also exhibited altered blood pressure control mechanisms. These studies expand the functional repertoire for AGS3 and other GPR proteins providing unexpected regulatory mechanisms by which G-protein systems may be targeted to influence obesity and cardiovascular function.


Key words: AGS3 • Gpsm1 • G-protein • GPR motif







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society